Aims We attempted to explore the possible differential involvement of badrenoceptor subtypes in the dilator response of the human dorsal hand vein to isoprenaline by examining the ability of bisoprolol, a selective b 1 -adrenoceptor antagonist, and nadolol, a nonselective b 1 /b 2 -adrenoceptor antagonist, to antagonize the response. Methods Twelve healthy male volunteers participated in four weekly sessions. In the preliminary session a dose-response curve to the vasoconstrictor effect of phenylephrine was constructed and the dose producing 50±75% maximal response was determined for each individual. In each of the remaining three (treatment) sessions, nadolol (40 mg), bisoprolol (5 mg) or placebo was ingested, and isoprenaline hydrochloride (3.33±1000 ng min x1 ) was infused locally into the dorsal hand vein along with a constant dose of phenylephrine hydrochloride (to preconstrict the vein) 2 h after the ingestion of the drugs. Changes in vein diameter were monitored with the dorsal hand vein compliance technique. Subjects were allocated to treatment session according to a double-blind balanced cross-over design. Systolic and diastolic blood pressure, and heart rate were also measured. Results Isoprenaline produced dose-dependent venodilatation which was antagonized by nadolol but remained unaffected by bisoprolol (ANOVA with repeated measures: P<0.025; Dunnett's test: placebo vs nadolol, P<0.01; placebo vs bisoprolol, P=NS). Mean log ED 50 (ng min x1 ) was signi®cantly increased in the presence of nadolol and remained unchanged in the presence of bisoprolol (ANOVA, P<0.025; Dunnett's test: placebo vs nadolol, P<0.005; placebo vs bisoprolol, P=NS; differences between mean log ED 50 [95% CI]: placebo vs bisoprolol x0.11 [-0.38, 0.16